Who owns Vor Biopharma Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VOR from SEC Form 13F filings across 102 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 102 institutions disclosed 48.5M shares of Vor Biopharma Inc. worth $893.0M — about 89.3% of shares outstanding; the largest disclosed holder is TCG Crossover Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
102
13F holders
$893.0M
value, 2026 filers
89.3%
of shares outstanding (48.5M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of VOR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | TCG Crossover Management, LLC | 5.7M | $104.4M | 2.5% | 10.4% | 0.0% |
| 2 | FMR LLC | 4.9M | $90.8M | 0.0% | 9.1% | +220.3% |
| 3 | FCPM III SERVICES B.V. | 4.1M | $75.8M | 10.1% | 7.6% | 0.0% |
| 4 | BlackRock, Inc. | 3.5M | $63.8M | 0.0% | 6.4% | +336.4% |
| 5 | Venrock Adviser, LLC | 3.0M | $56.0M | 1.7% | 5.6% | 0.0% |
| 6 | STATE STREET CORP | 2.6M | $48.2M | 0.0% | 4.8% | +133.9% |
| 7 | Frazier Life Sciences Management, L.P. | 2.5M | $46.8M | 1.0% | 4.7% | 0.0% |
| 8 | RA CAPITAL MANAGEMENT, L.P. | 2.4M | $44.2M | 0.4% | 4.4% | -55.6% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | $38.4M | 0.0% | 3.8% | +45.4% |
| 10 | Caligan Partners LP | 1.9M | $35.4M | 1.7% | 3.5% | 0.0% |
| 11 | Paradigm Biocapital Advisors LP | 1.8M | $32.2M | 0.6% | 3.2% | 0.0% |
| 12 | GREAT POINT PARTNERS LLC | 1.7M | $31.3M | 5.9% | 3.1% | -2.9% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $19.6M | 0.0% | 2% | +210.1% |
| 14 | NEXTBio Capital Management LP | 889,164 | $16.4M | 7.5% | 1.6% | -11.1% |
| 15 | Nantahala Capital Management, LLCNEW | 845,000 | $15.6M | 0.5% | 1.6% | new |
| 16 | ADAR1 Capital Management, LLCNEW | 680,626 | $12.5M | 0.6% | 1.3% | new |
| 17 | Logos Global Management LP | 650,000 | $12.0M | 0.5% | 1.2% | -13.3% |
| 18 | Rosalind Advisors, Inc. | 648,600 | $11.9M | 4.4% | 1.2% | -7.3% |
| 19 | NAN FUNG TRINITY (HK) LTDNEW | 646,550 | $11.9M | 1.2% | 1.2% | new |
| 20 | BRAIDWELL LP | 573,104 | $10.6M | 0.4% | 1.1% | +22.8% |
| 21 | BOOTHBAY FUND MANAGEMENT, LLC | 558,702 | $10.3M | 0.1% | 1% | +0.5% |
| 22 | UBS Group AG | 493,278 | $9.1M | 0.0% | 0.9% | +1.0% |
| 23 | MILLENNIUM MANAGEMENT LLC | 428,067 | $7.9M | 0.0% | 0.8% | +65.5% |
| 24 | SPHERA FUNDS MANAGEMENT LTD. | 416,417 | $7.7M | 1.0% | 0.8% | +29.4% |
| 25 | Woodline Partners LPNEW | 379,723 | $7.0M | 0.0% | 0.7% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.